mds 2023 highlights: classification and risk stratification systems & progression from ch to mds
Published 1 year ago • 99 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:51
factors driving the transformation of chip to mds
-
0:58
risk stratification in mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
3:57
validation of the ipss-m risk stratification system in mds
-
1:18
the importance risk stratification to enable risk-adapted therapy in mds & cmml
-
1:43:41
advances in our understanding of the management of mds
-
1:55:04
mdsr 2024: clinical higher risk mds
-
49:25
myelodysplastic syndrome (mds) and anemia
-
0:55
the use of ngs to better risk stratify patients & identify druggable mutations in mds
-
33:19
mds - myeloplastic syndromes - 2023 best of hematology conference
-
5:14
prognostic value of the updated icc and who classifications for mds
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:40
highlights in lr-mds at the ash 2023 meeting
-
3:11
clinical characteristics of h-mds
-
3:22
performance of the aipss-mds ml model in predicting os & leukemic transformation in cmml
-
13:39
key highlights in mds: treating lower-risk & higher-risk disease, trial updates, and more
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:02
emerging treatment options for lower- and higher-risk mds and ongoing trials
-
1:38
mds 2023
-
0:51
similarities between the who and icc classifications for mds & the need to create a unified approach
-
6:04
relevance of ipss-r for risk stratification in patients with mds who undergo sct